{ }
Symbol AMZN
Name Amazon.com, Inc.
Currency USD
Sector Consumer Discretionary
IndustryGroup Retailing
Industry Internet & Direct Marketing Retail
Market NASDAQ Global Select
Country United States
State WA
City Seattle
Zipcode 98109-5210
Website http://www.amazon.com
Ethena Labs has proposed integrating its synthetic stablecoin, sUSDe, into the World Liberty Financial (WLFI) protocol, aiming to enhance capital efficiency and liquidity. This partnership, if approved, would leverage sUSDe's high annual percentage yield of 27% to boost user rewards and total value locked in WLFI's Aave instance, which is backed by Donald Trump's family. The integration has already shown success in Aave, achieving $1.2 billion in supplied assets shortly after onboarding.
Nvidia's stock rose over 3% as analysts from Bernstein, TD Cowen, Morgan Stanley, and Truist maintained bullish ratings despite concerns about competition and potential declines in AI chip demand. Truist raised its price target to $204, citing Nvidia's technological superiority.However, worries persist as major tech companies like Google and Meta develop custom chips that could threaten Nvidia's market share. Analysts acknowledge the challenges but emphasize Nvidia's historical dominance and confidence in ongoing industry innovation.
UBS has raised its target price for Amazon.com, Inc. from $230 to $264, maintaining a Buy rating due to the company's enhancements in one-day and same-day Prime delivery and growth in high-margin revenue streams like ad-supported Prime Video. The average price target from 65 analysts stands at $237.24, with estimates ranging from $180.00 to $285.00. GuruFocus estimates a GF Value of $181.39 for Amazon in one year, indicating a potential downside of 21.53% from the current price of $231.15.
UBS has raised its target price for Amazon.com, Inc. from $230 to $264, maintaining a Buy rating due to the company's enhancements in one-day and same-day Prime delivery and growth in high-margin revenue streams like ad-supported Prime Video. The average price target from 65 analysts stands at $237.24, with estimates ranging from $180.00 to $285.00. GuruFocus estimates a GF Value of $181.39 for Amazon in one year, indicating a potential downside of 21.53% from the current price of $231.15.
UBS has raised its target price for Amazon.com, Inc. from $230 to $264, maintaining a Buy rating due to the company's enhancements in one-day and same-day Prime delivery and growth in high-margin revenue streams like ad-supported Prime Video. The average price target from 65 analysts stands at $237.24, with estimates ranging from $180.00 to $285.00. However, GuruFocus estimates a GF Value of $181.39 for Amazon in one year, indicating a potential downside of 21.53% from the current price of $231.15.
UBS has raised its target price for Amazon.com, Inc. from $230 to $264, maintaining a Buy rating due to the company's enhancements in one-day and same-day Prime delivery and growth in high-margin revenue streams like ad-supported Prime Video. The average price target from 65 analysts stands at $237.24, with estimates ranging from $180.00 to $285.00. However, GuruFocus estimates a GF Value of $181.39 for Amazon in one year, indicating a potential downside of 21.53% from the current price of $231.15.
Shares dipped slightly on Wednesday morning, with Nvidia rebounding 2.5% in premarket trading after a four-day losing streak. The Dow Jones Industrial Average rose 0.3% ahead of a Federal Reserve interest rate decision, while notable stocks like Amazon and Apple reached new highs. IBM and BlackRock are nearing key buy points, while Tesla faced a decline after recent gains.
Nestlé has launched protein shots in the US aimed at weight-loss drug users, designed to suppress appetite by mimicking the GLP-1 hormone response. The Boost Pre-Meal Hunger Support shake, containing whey protein and low calories, is intended to be consumed before meals and is priced at $10.99 per pack. While it may enhance satiety, experts question its long-term effectiveness compared to traditional weight loss methods.
Nestle has launched protein shots in the U.S. aimed at appetite suppression for those using weight-loss medications like Wegovy. Priced at $10.99 for a pack of four, the shots contain whey protein and are designed to enhance the body's natural GLP-1 response, promoting a feeling of fullness before meals. While the product is not a substitute for weight-loss drugs, it may assist in weight management.
Investors are concerned that Trump's potential trade tariffs could exacerbate inflation, as retail sales rose 0.7% in November. The Dow Jones is on track for its longest losing streak since the 1970s, while Nvidia faces challenges with thermal issues in its chips, impacting its stock. Tesla continues to rise, with analysts projecting a bullish outlook for 2025.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.